Prof Andreas Heise

Associate Professor of Chemistry and Head of Polymer Chemistry and Biopolymers Laboratory (RCSI)

Prof. Heise is heading the Polymer Chemistry and Biopolymer Labs in the Royal College of Surgeons in Ireland (RCSI). Over the last number of years he has established a critical mass of polymer and functional soft material expertise in Ireland. His research employs the concepts of macromolecular engineering to modulate polymer properties by controlled structural design and functionalisation for advanced applications, for example in biomaterial science.

Prof. Heise has developed a range of polymeric materials from synthetic building blocks employing controlled radical as well as ring-opening polymerisation. A special focus of the group is on synthetic polypeptides. In collaboration with the School of Pharmacy at RCSI he has developed branched polypeptides as novel biomimetic hydrogels and gene delivery vectors. These materials are based on amino acids and are fully biocompatible, and due to the polymerisation approach tuneable on molecular level to meet application demands.

Prof. Heise has previously worked as a Senior Industrial Researcher in the polymer industry (DSM) and was awarded a Science Foundation Ireland Stokes Lectureship in 2008. In his previous position at DCU he established the first dedicated polymer research group in Ireland for which he received the DCU President’s Research Award in recognition of outstanding research achievements. Prof. Heise has published more than 130 papers in peer-reviewed journals, several book chapters and filed several patent applications.


Prof Sally-Ann Cryan

Associate Professor in Pharmaceutics / Research Convenor for School of Pharmacy (RCSI)

Prof. Cryan is Associate Professor of Pharmaceutics and Research Lead in the School of Pharmacy, Royal College of Surgeons in Ireland (RCSI) ( Her Drug Delivery and Advanced Materials (DReAM) research team focuses on translational drug delivery and bioengineering including the application and processing of materials for drug delivery and tissue engineering applications. The platforms have been developed for application in tuberculosis, cystic fibrosis and acute lung injury, inflammatory disease and cancer as well as in regenerative medicine including respiratory, orthopaedic and cardiovascular applications. Prof. Cryans team is part of the RCSI Tissue Engineering Research Group (TERG) ( and she is a PI in the Trinity Centre for Biongineering ( and a funded investigator in the SFI Centre for Research in Medical Devices (CURAM) (

Prof. Cryan has established a large, well-funded research group and both she and her team have received a number of academic and professional awards for their work. Prof. Cryan herself was awarded the Fulbright Scholarship in Science & technology (Medicine) in 2003 and the Professional Excellence Award at the Helix Health Pharmacy Awards (2014) and her team’s research has won a number of prizes at both national and international conferences.

Prof. Cryan has filed a number of patent applications and has over 120 publications/presentations in pharmaceutics and biomaterials peer-reviewed and professional journals as well as academic, industrial and clinical conferences. She works extensively with the pharmaceutical and medical device industry including spin-outs, SMEs and MNCs in the areas of drug product development and pharmaceutical technology. This has included both contract research and joint research programmes and she is an associated partner on a European Industrial Doctorate (EID).


©2017 by TREND materials. Proudly created with

AMBER Centre.jpg